Affordable Access

Airtraq® for awake tracheal intubation

Wiley Blackwell (Blackwell Publishing)
Publication Date


Correspondence AMCoR Asahikawa Medical College Repository Anaesthesia. (2007) 62(7): 746-747. Airtraq ® for awake tracheal intubation. Suzuki A, Toyama Y, Iwasaki H, Henderson J. Airtraq® for awake tracheal intubation The Airtraq (Prodol Meditec S.A., Vizcaya, Spain) is a new single-use tracheal intubation device which is passed over the dorsum of the tongue to provide an indirect view of the glottis without the need to achieve a direct line of sight by conventional use of the ‘sniff’ position and displacement of the tongue to the left. Because the tongue is not displaced and forceful elevation of the epiglottis is not required, the Airtraq probably requires less force to be applied than during conventional direct laryngoscopy [1]. It should therefore be suitable for awake intubation. We used the Airtraq for awake tracheal intubation of an elderly woman with gastro-oesophageal regurgitation after previous proximal gastrectomy and was scheduled for residual gastrectomy. She had a known history of difficult laryngoscopy (Cormack & Lehane grade 3). A rapid sequence technique with cricoid pressure was not attempted because she was at risk of regurgitation in the presence of difficult intubation. Therefore, awake intubation was scheduled. The patient's oral cavity was topicalised with lidocaine 8% spray before intubation was attempted. An initial attempt with the conventional Macintosh blade was unsuccessful because laryngoscopy was difficult and poorly tolerated due to an active gag reflex. An attempt was next made with the Airtraq with some modification of the device (Figure 1). The tracheal tube was placed in the side channel of the airtraq and connected to the respiratory circuit via a Bodai Suction Safe® swivel Y-connector (Sontec Medical, Massachusetts, USA). Oxygen at 10 l.min-1 was administered to prevent both desaturation of the patient and to re

There are no comments yet on this publication. Be the first to share your thoughts.


Seen <100 times